[SGMO] QoQ Quarter Result on 31-Dec-2022 [#Q4]

Stock
[SGMO] Sangamo Therapeutics, Inc.
Announcement Date
22-Feb-2023
Financial Year
2022
Quarter
31-Dec-2022 [#Q4]
Profit Trend
QoQ- 2.22%
YoY- -38.61%
Quarter Report
SGMO's Result
SGMO's Financial Summary
View:
Show?
Quarter Result
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
Revenue 9,398 6,835 157,957 27,230 26,460 29,378 28,231 -51.93%
PBT -102,893 -120,770 21,327 -51,714 -53,125 -43,091 -43,919 76.30%
Tax 1,270 -6,264 194 259 30 82 58 681.21%
NP -104,163 -114,506 21,133 -51,973 -53,155 -43,173 -43,977 77.59%
Tax Rate - - -0.91% - - - - -
Total Cost 113,561 121,341 136,824 79,203 79,615 72,551 72,208 35.19%
Ratio Analysis
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
NP Margin -1,108.35 -1,675.29 13.38 -190.87 -200.89 -146.96 -155.78 269.48%
Per Share
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
EPS -0.59 -0.66 0.13 -0.32 -0.34 -0.29 -0.30 56.90%
EPS Diluted -0.59 -0.66 0.12 -0.32 -0.34 -0.29 -0.30 56.90%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.